These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


387 related items for PubMed ID: 28095872

  • 1. An unusual combined thymic carcinoma composed of squamous cell carcinoma and type AB thymoma: a rare case report.
    Jiang Y, Liu Y, Shi X, Mao X, Zhao Y, Fan C.
    Diagn Pathol; 2017 Jan 17; 12(1):9. PubMed ID: 28095872
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.
    Thomas de Montpréville V, Quilhot P, Chalabreysse L, De Muret A, Hofman V, Lantuéjoul S, Parrens M, Payan MJ, Rouquette I, Secq V, Girard N, Besse B, Marx A, Molina TJ.
    Pathol Res Pract; 2015 Dec 17; 211(12):996-1002. PubMed ID: 26534878
    [Abstract] [Full Text] [Related]

  • 6. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
    Fukumoto K, Taniguchi T, Ishikawa Y, Kawaguchi K, Fukui T, Kato K, Matsuo K, Yokoi K.
    Eur J Cardiothorac Surg; 2012 Dec 17; 42(6):e152-6. PubMed ID: 23024234
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma.
    Pfister F, Hussain H, Belharazem D, Busch S, Simon-Keller K, Becker D, Pfister E, Rieker R, Ströbel P, Marx A.
    Histopathology; 2017 Apr 17; 70(5):693-703. PubMed ID: 27791295
    [Abstract] [Full Text] [Related]

  • 12. Metaplastic thymoma: report of an unusual thymic epithelial neoplasm arising in the wall of a thymic cyst.
    Poorabdollah M, Mehdizadeh E, Mohammadi F, Sabeti S.
    Int J Surg Pathol; 2009 Feb 17; 17(1):51-4. PubMed ID: 18397900
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Using the World Health Organization Classification of thymic epithelial neoplasms to describe CT findings.
    Tomiyama N, Johkoh T, Mihara N, Honda O, Kozuka T, Koyama M, Hamada S, Okumura M, Ohta M, Eimoto T, Miyagawa M, Müller NL, Ikezoe J, Nakamura H.
    AJR Am J Roentgenol; 2002 Oct 17; 179(4):881-6. PubMed ID: 12239030
    [Abstract] [Full Text] [Related]

  • 16. The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma.
    Li H, Ren B, Yu S, Gao H, Sun PL.
    BMC Cancer; 2023 Feb 16; 23(1):161. PubMed ID: 36797681
    [Abstract] [Full Text] [Related]

  • 17. The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma.
    Hayashi A, Fumon T, Miki Y, Sato H, Yoshino T, Takahashi K.
    J Clin Exp Hematop; 2013 Feb 16; 53(1):9-19. PubMed ID: 23801129
    [Abstract] [Full Text] [Related]

  • 18. CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma.
    Kanamori K, Suina K, Shukuya T, Takahashi F, Hayashi T, Hara K, Saito T, Mitsuishi Y, Shimamura SS, Winardi W, Tajima K, Ko R, Mimori T, Asao T, Itoh M, Kawaji H, Suehara Y, Takamochi K, Suzuki K, Takahashi K.
    Thorac Cancer; 2023 Apr 16; 14(12):1089-1097. PubMed ID: 36924358
    [Abstract] [Full Text] [Related]

  • 19. Concurrent thymoma, thymic carcinoma, and T lymphoblastic leukemia/lymphoma in an anterior mediastinal mass.
    Ito J, Yoshida A, Maeshima AM, Nakagawa K, Watanabe S, Kobayashi Y, Fukuhara S, Tsuta K.
    Pathol Res Pract; 2015 Sep 16; 211(9):693-6. PubMed ID: 26150396
    [Abstract] [Full Text] [Related]

  • 20. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
    Walts AE, Hiroshima K, Marchevsky AM.
    Ann Diagn Pathol; 2015 Aug 16; 19(4):216-20. PubMed ID: 25979154
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.